These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12510570)

  • 1. Birth defects surveillance.
    Smulian JC; Beres-Sochka L; DePrince K; Canterino J; Fischer R; Apuzzio J; Royle M
    N J Med; 2002 Dec; 99(12):25-31. PubMed ID: 12510570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methodological issues in setting up a surveillance system for birth defects in India.
    Suresh S; Thangavel G; Sujatha J; Indrani S
    Natl Med J India; 2005; 18(5):259-62. PubMed ID: 16433142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based study of birth defects in Malaysia.
    Thong MK; Ho JJ; Khatijah NN
    Ann Hum Biol; 2005; 32(2):180-7. PubMed ID: 16096215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Registry to referral: using birth defects registries to refer infants and toddlers for early intervention services.
    Farel AM; Meyer RE; Hicken M; Edmonds LD
    Birth Defects Res A Clin Mol Teratol; 2003 Sep; 67(9):647-50. PubMed ID: 14703788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Including prenatal diagnoses in birth defects monitoring: Experience of the Metropolitan Atlanta Congenital Defects Program.
    Cragan JD; Gilboa SM
    Birth Defects Res A Clin Mol Teratol; 2009 Jan; 85(1):20-9. PubMed ID: 19089857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a web-based integrated birth defects surveillance system in New York State.
    Wang Y; Tao Z; Cross PK; Le LH; Steen PM; Babcock GD; Druschel CM; Hwang SA
    J Public Health Manag Pract; 2008; 14(6):E1-E10. PubMed ID: 18849767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurements of birth defect prevalence: which is most useful as a comparator group for pharmaceutical pregnancy registries?
    Scheuerle A; Vannappagari VX; Miller MK
    Birth Defects Res A Clin Mol Teratol; 2009 Jul; 85(7):611-20. PubMed ID: 19215016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sources of variability in birth defects prevalence rates.
    Hobbs CA; Hopkins SE; Simmons CJ
    Teratology; 2001; 64 Suppl 1():S8-S13. PubMed ID: 11745838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of prenatal diagnostic procedures in pregnancies affected with birth defects, Hawaii, 1986-2002.
    Forrester MB; Merz RD
    Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):778-80. PubMed ID: 17019733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study.
    Canfield MA; Collins JS; Botto LD; Williams LJ; Mai CT; Kirby RS; Pearson K; Devine O; Mulinare J;
    Birth Defects Res A Clin Mol Teratol; 2005 Oct; 73(10):679-89. PubMed ID: 16240378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal detection of birth defects in a Malaysian population: estimation of the influence of termination of pregnancy on birth prevalence in a developing country.
    Ho JJ; Thong MK; Nurani NK
    Aust N Z J Obstet Gynaecol; 2006 Feb; 46(1):55-7. PubMed ID: 16441696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monitoring of pregnancies exposed to drugs in France: the experience of the registries of congenital malformations].
    Doray B
    Therapie; 2014; 69(1):47-51. PubMed ID: 24698188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the changes of incidence rates on birth defects through hospital based surveillance program in Guangdong province during 1997-2007].
    Li B; Zhang XZ; Ye N; Mu L; Xia JH; Huang XJ; He SL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Nov; 29(11):1101-5. PubMed ID: 19173933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paper 1: The EUROCAT network--organization and processes.
    Boyd PA; Haeusler M; Barisic I; Loane M; Garne E; Dolk H
    Birth Defects Res A Clin Mol Teratol; 2011 Mar; 91 Suppl 1():S2-15. PubMed ID: 21384531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The National Congenital Anomalies Register in the United Arab Emirates.
    Al Hosani H; Salah M; Abu-Zeid H; Farag HM; Saade D
    East Mediterr Health J; 2005 Jul; 11(4):690-9. PubMed ID: 16700385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of using the national hospital discharge survey to estimate the prevalence of selected birth defects.
    Boulet SL; Correa-Villaseñor A; Hsia J; Atrash H
    Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):757-61. PubMed ID: 17094134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence is the preferred measure of frequency of birth defects.
    Mason CA; Kirby RS; Sever LE; Langlois PH
    Birth Defects Res A Clin Mol Teratol; 2005 Oct; 73(10):690-2. PubMed ID: 16240384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of capture-mark-recapture method on evaluating the abilities of birth defects surveillance systems].
    Yin XQ; Li YM; Luo JY; Shi XJ; Yin T; Huang R; Chen J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Feb; 29(2):155-7. PubMed ID: 18686856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National rates of birth defects among hospitalized newborns.
    Bird TM; Hobbs CA; Cleves MA; Tilford JM; Robbins JM
    Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):762-9. PubMed ID: 17063529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organizing population data into complex family pedigrees: application of a second-order data linkage to state birth defects registries.
    Tu S; Mason CA
    Birth Defects Res A Clin Mol Teratol; 2004 Sep; 70(9):603-8. PubMed ID: 15368560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.